2020 highlights!
2020 is coming to its end, a year with great difficulties and challenges. However, this year, more than ever, we have proved the strength of our research.
December 2020
Combined therapy could be a solution for EGFR inhibitor-resistant skin squamous cell cancers
A team from IDIBELL has deciphered the molecular mechanisms responsible for resistance to EGFR inhibitors and offers new therapeutic strategies.
Discovered a new biomarker candidate to diagnose early cases of ALS
CXCL12 protein levels are increased in cerebrospinal fluid of patients with sporadic Amyotrophic Lateral Sclerosis (sALS) and also in Multiple Sclerosis (ME).
Iron treatment reduces the risk of hospitalization in people with heart deficiencies
Results, released simultaneously at the American Heart Association (AHA) 2020 virtual conference and in the journal The Lancet, show that patients who received the iron supplement were 26% less likely to be readmitted to the hospital for heart failure compared to the control group.
Spain is one of the most permissive states with the tobacco industry interference in tobacco control
This is one of the results indicated by the latest report of the ‘Global Tobacco Industry Interference Index’ published this November and in which Spain obtains a score that places it behind 35 countries out of the 57 analyzed.
A study evaluates the effectiveness of colon and gynecological surgeries and their risk reduction in patients affected by Lynch syndrome
The results show that this type of surgery can represent a good option for people affected by this syndrome since it supposes a reduction in the incidence of cancer and its mortality.
A multicenter approach improves genetic variants classification of a cancer predisposition gene
The correct classification of genetic variants can help in the early diagnosis and personalized treatment of cancer in patients who carry this gene.
The close relationship between gambling and video games
Not all video games are the same in terms of addictive potential, nor all patterns of behavior can be considered risky. But the scientific community agrees, and also among some regulators, is that the so-called “reward boxes”, or loot boxes, seem to be on the border between video games and gambling.
Scientists discover the immunomodulatory activity of a drug that would improve the efficacy of immunotherapy against breast cancer
The team of Dr. Eva González-Suarez, from the CNIO and IDIBELL, and the team of Dr. Christos Sotiriou, from the Jules Bordet Institute, demonstrate that a drug already used to treat osteoporosis promotes the infiltration of immune cells in breast tumors.
The team led by Dr. M. Carolina Florian at IDIBELL receives a European grant of 2 million euros to study bone marrow rejuvenation
With this project, Dr. M Carolina Florian, from the IDIBELL’s Regenerative Medicine Program, aims to improve the survival and quality of life of elderly patients undergoing chemotherapy.